MAGDALENA CAUDILLO: Open Payments
NPI 1659345577 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 13 payments from 5 companies in 2025. Trend: 2023 $72 · 2024 $149 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $111 |
| Amgen Inc. | 6 | $106 |
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lilly USA, LLC | 1 | $20 |
Products named: Dexcom G6 Transmitter, OTEZLA, Rybelsus, KRYSTEXXA, MOUNJARO, Ozempic, AIRSUPRA, FARXIGA.
Industry payments across TX — which companies pay providers there.
